Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Chitosan-coated spironolactone nano carriers effectively treat acne without side effects.

Specialized techniques are needed for hair restoration in individuals with curly Afrocentric hair due to unique challenges.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Laser hair removal improves life quality short-term for women with PCOS-related hirsutism.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Sertraline can cause hair loss, which stops after stopping the drug.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Eating certain seeds may help reduce symptoms of Polycystic Ovary Syndrome.

Women with cicatricial hair loss may have a higher risk of hypertension.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

PSA could be a marker for hyperandrogenism in women, but more research is needed.